KKR healthcare vet Jim Momtazee jump starts a new investment firm; Bayer signs up a top China biotech player to $645M deal
A year after Jim Momtazee stepped out of his lead role in charge of healthcare for private equity giant KKR, it’s time for the big reveal on what he’s been working on.
This morning Momtazee unveiled Patient Square Capital, which he says is “being purpose-built to become the preeminent investment firm in healthcare.”
Nothing small about that. And KPMG vet Maria Walker is coming in as partner and CFO of Patient Square.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.